Efficacy of nimotuzumab added to concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma

被引：0
|
作者：
Wu, Sangang
Wang, Runjie
Yu, Yifeng
Zhou, Ping
Lian, Chenlu
Wang, Jun
Lin, Qin
机构：
[1] First Affiliated Hosp Xiamen Univ, Xiamen, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Xiamen Branch, Xiamen, Peoples R China
[3] Sichuan Univ, West China Hosp, Ctr Canc, Div Head & Neck Tumor Multimodal Treatment, Chengdu, Peoples R China
[4] First Affiliated Hosp Xiamen Univ, Dept Radiat Oncol, Xiamen, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
    Wang, Run-Jie
    Ke, Rui-Quan
    Yu, Yi-Feng
    Lu, Guan-Zhong
    Wu, San-Gang
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] Effect of nimotuzumab and PF induction chemotherapy combined with concurrent chemoradiotherapy in treating locally advanced nasopharyngeal carcinoma
    Gao, Min
    Yuan, Tiejun
    Zhang, Fangxiang
    [J]. JOURNAL OF BUON, 2021, 26 (01): : 116 - 123
  • [3] Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
    Song, Xinmao
    Wang, Shengzi
    Li, Ji
    Yan, Li
    Chen, Fu
    Wang, Jie
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (05) : 1317 - 1324
  • [4] Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma
    Wang, Lili
    Zhuang, Hengzhao
    Xu, Xiaoyan
    Zhou, Juying
    Jiao, Yang
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma
    Luan, Weihong
    Yuan, Haozhan
    Hou, Wei
    Li, Jing
    Liu, Liping
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (08): : 5630 - 5640
  • [6] The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy
    Guo, Lin-Feng
    Rao, Ming-Yue
    Yu, Yi-Feng
    Lin, Qin
    Wu, San-Gang
    [J]. BMC CANCER, 2024, 24 (01)
  • [7] Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
    Xu, Guoqiang
    Wang, Qiaoli
    Wu, Xingrao
    Lv, Chunyan
    Zeng, Guilin
    Xue, Zhihong
    Cao, Ruixue
    Zhang, Nan
    Xiong, Wei
    Huang, Qin
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [8] Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wang, Fangzheng
    Jiang, Chuner
    Ye, Zhimin
    Sun, Quanquan
    Liu, Tongxin
    Xu, Min
    Wu, Peng
    Shi, Kaiyuan
    Long, Bin
    Rihito, Aizawa
    Masoto, Sakamoto
    Fu, Zhenfu
    [J]. ONCOTARGET, 2017, 8 (43) : 75544 - 75556
  • [9] Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis
    Liu, Zhi-gang
    Zhao, Yu
    Tang, Jiao
    Zhou, Yu-juan
    Yang, Wen-juan
    Qiu, Yan-fang
    Wang, Hui
    [J]. ONCOTARGET, 2016, 7 (17) : 24429 - 24435
  • [10] The role of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    Lee, K.
    Hee, S.
    Wee, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S424 - S425
12345